Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2021 / Cilt: 31 - Sayı: 1

A Rare Case of Malignancy: Biphasic Primary Pulmonary Synovial Sarcoma

Ender Bir Malignite Olgusu: Bifazik Primer Pulmoner Sinovyal Sarkom

Pages
120–125
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further investigations have shown that our patient is a rare form of biphasic synovial sarcoma originating from the pulmonary system, which is rarely reported in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Synovial sarcoma is a highly aggressive malignancy with a 10-year disease-free survival of around 50%.
📊
Key Findings & Data:Synovial sarcoma accounts for 5 to 10% of all soft tissue sarcomas.
💡
Conclusion & Impact:Further investigations have shown that our patient is a rare form of biphasic synovial sarcoma originating from the pulmonary system, which is rarely reported in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Synovial sarcoma is a highly aggressive malignancy with a 10-year disease-free survival of around 50%. Synovial sarcoma accounts for 5 to 10% of all soft tissue sarcomas. It is more common in young people and adolescents and it is seen in lower extremities, especially around the knee. The prognosis of the disease is worse in the elderly population. Microscopic imaging, positive staining of epithelial markers and molecular study are required to confirm the the presence of the disease. We present a 44-year-old male patient with a history of falling from the same level and presenting with only shoulder pain. Further investigations have shown that our patient is a rare form of biphasic synovial sarcoma originating from the pulmonary system, which is rarely reported in the literature.

Özet

noviyal sarkom oldukça agresif seyreden bir malignitedir ve 10 yıllık hastalıksız sağkalım %50 civarındadır. Sinoviyal sarkom tüm yumuşak doku sarkomlarının %5 ila 10’unu oluşturur. Gençlerde ve adolesanlarda daha sık saptanmakta olup, alt ekstremitelerde, özellikle diz çevresinde görülme sıklığı yüksektir. Yaşlı popülasyonda hastalığın prognozu daha kötü seyretmektedir. Hastalığın doğrulanması için mikroskobik görüntüleme, epitel belirteçlerinde ve moleküler çalışmada pozitif boyanma gereklidir. Hastanemize daha öncesinde aynı seviyeden düşme öyküsü olan ve yalnızca omuz ağrısıyla başvuran 44 yaşındaki erkek bir olgu sunulmaktadır. Yapılan ileri tetkikler ile hastamızın oldukça ender bir form olan ve literatürde az sayıda bildirilen pulmoner sistem kaynaklı bifazik sinoviyal sarkom olgusu olduğu gösterilmiştir.

🔖

Cite This Article

AKGÜN, K. B., ÇALIKOĞLU, M., ARPACI, R. B., ERGEN, P. (2021). A Rare Case of Malignancy: Biphasic Primary Pulmonary Synovial Sarcoma. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 31 - Sayı: 1, 120–125. https://ajindex.com/articles/347808

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. de Silva MV, McMahon AD, Reid R. Prognostic Factors Associated With Local Recurrence, Metastases, and TumorRelated Death in Patients With Synovial Sarcoma. Am J Clin Oncol. 2004;27(2):113-21. [CrossRef] 2. Elezoglu B, Asik N, Kasap Kilicoglu M, Yalcinkaya U. Sinovial Sarkom Olgularımızın Genel Ozellikleri. Uludag Univ Tip Fak Derg. 2010;36(2):55-9. 3. Falkenstern-Ge RF, Kimmich M, Grabner A et al. Primary Pulmonary Synovial Sarcoma: A Rare Primary Pulmonary Tumor. Lung. 2014;192(1):211-4. [CrossRef] 4. Paulino AC. Synovial Sarcoma Prognostic Factors and Patterns of Failure. Am J Clin Oncol. 2004;27(2):122-7. [CrossRef] 5. Zeren H, Moran CA, Suster S, Fishback NF, Koss MN. Primary pulmonary sarcomas with features of monophasic synovial sarcoma: a clinicopathological, immunohistochemical, and ultrastructural study of 25 cases. Hum Pathol. 1995;26(5):474- 80. [CrossRef] 6. Bhattacharya D, Datta S, Das A, Halde KC, Chattopadhyay S. Primary pulmonary synovial sarcoma: A case report and review of literature. Int J of Appl Basic Med Res. 2016;6(1):63-5. [CrossRef] 7. Braham E, Aloui S, Aouadi S, Drira I, Kilani T, El Mezni F. Synovial sarcoma of the chest wall: a case report and literature review. Ann Transl Med. 2013;1(1):9. 8. Ferrari A, Gronchi A, Casanova M et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004;101(3):627-34. [CrossRef] 9. Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol. 2011;135(6):839-44. [CrossRef] 10. Kosemehmetoglu K, Vrana JA, Folpe AL. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Mod Pathol. 2009;22(7):872-8. [CrossRef]